CDC panel, newly remade by RFK Jr., questions vaccine evidence

New members of the ACIP panel raised questions about the evidence supporting COVID vaccines, and signaled plans to look at other established shots, like those for measles and hepatitis B.

Acadia’s ‘very bullish’ sales forecast restores some confidence on Wall Street

The brain drug developer is now saying that its two marketed products could ultimately bring in $2 billion annually, and its pipeline may one day add another $12 billion in sales each year.

Relentless innovation: Bold exploration in advancing therapeutic options for every patient, every discovery

Recast CDC panel recommends new RSV antibody for infants

By a 5-2 vote, the Advisory Committee on Immunization Practices endorsed Merck’s Enflonsia for babies born during or entering their first RSV season.